The World Health Organization (WHO) Director-General announced Wednesday that a clinical trial for two new Ebola treatments will begin next week. This trial focuses on the Bundibugyo strain of the virus, a less common variant for which no existing vaccine or specific treatment is currently available. The initiative aims to evaluate the effectiveness of these potential therapies in combating this particular Ebola strain. Currently, there is an urgent need for medical countermeasures against Bundibugyo Ebola, as outbreaks have occurred with limited options for patient care. The WHO is coordinating the trial to accelerate the development of effective treatments. This represents a significant step forward in addressing a critical gap in global health security regarding Ebola preparedness.